澳大利亚临床试验中的公众参与:系统性审查
Tessa-May Zirnsak1, Ashley H Ng2,3, Catherine Brasier1
1Social Work and Social Policy, La Trobe University, Melbourne, VIC, Australia.
Clinical trials (London, England)
|February 26, 2024
概括
澳大利亚临床试验中的公众参与率很低 (5%),明显低于英国. 这可能是由于缺乏研究人员培训和为公众参与研究提供资金的任务.
科学领域:
- 临床试验 临床试验
- 医疗保健服务研究 医疗服务研究
- 公共卫生 公共卫生
背景情况:
- 公共参与对于研究的相关性,质量和影响至关重要.
- 有证据表明,与英国相比,澳大利亚的研究参与率较低.
- 系统性审查,以评估公众参与澳大利亚临床试验.
研究的目的:
- 确定公众参与澳大利亚临床试验的比例.
- 描述公众参与这些试验的特点.
主要方法:
- 澳大利亚随机对照试验 (RCT) 的系统审查于2021年初发表.
- 评估公众参与的质量,使用"患者和公众参与报告指南" (GRIPP2) 简式.
主要成果:
- 在325个RCT中,有17个 (5%) 报告公众参与.
- 公众参与制定研究目标 (6项试验) 和开发研究方法 (7项试验).
- 一项研究反映了公众参与的整体作用和影响.
结论:
- 澳大利亚临床试验中的公众参与似乎比英国等同等国家要低得多.
- 潜在的原因包括研究人员技能不足和资助机构缺乏强制性公众参与.
- 解决这些因素可以提高公众对澳大利亚研究的参与度.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.3K
06:16Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
3.7K
相关概念视频
Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
